Sentence examples for formally deficient from inspiring English sources
For example, the 2004 guidelines of the Institute of Medicine specify a DRI of 4,700 mg of potassium (100 mEq), though most Americans consume only half that amount per day, which would make them formally deficient as regards this particular recommendation.
Future whole-transcriptome experiments of relevant UPF2 deficient tissues will formally test this possibility.
(It remains formally possible that this phosphorylation-deficient Atf1 protein is phosphorylated at non-canonical phospho-acceptor sites and that such events somehow escaped detection).
There is therefore a need for confirmatory trials to formally assess primaquine safety in G6PD-deficient individuals, in particular with the World Health Organization recommended dose of 0.25 mg/kg.
It remained formally possible that Bim- and/or Bmf-deficient non-hematopoietic cells such as intestinal epithelial cells or adipocytes contribute to improved B-cell survival either by producing increased BAFF levels, outcompeting the capacity of TACI-Ig, or by providing alternative B-cell extrinsic survival factors that may compensate for the loss of BAFF.
With the generation of a completely deficient actin-binding mutant of Coro1C, we now have the ability to formally assess the actin-binding function of Coro1C in a variety of physiological contexts.
While this is formally true given the high levels of IFNg and antibody production seen in CTLA-4 deficient mice, it does not seem likely that CTLA-4 enhances Tfh, Th1 or Germinal center formation.
Although unlikely, we can at this stage not formally exclude an eventual difference in the transcriptional activity of AP1 between WT and Ripk1-deficient cells (a similar remark can also be made for CHOP).
This regenerative phenotype allowed us to formally establish roles for macrophages, and CCR2, in contributing to the lymphatic vessel density phenotype in ACKR2-deficient mice.
To formally test whether the combination of FK866 and olaparib could increase the therapeutic window in a HR-deficient setting, we assessed the effect of FK866/Olaparib on isogenic DLD1 BRCA2+/+ and BRCA2−/− cells.
